Difference Between Homeopathic High Potencies (Above 12c), Low Potencies (Below 12c) And Crude Drugs
On the basis of the concept of potentization as ‘molecular imprinting’ discussed in my article “DIALECTICAL HOMEOPATHY”, homeopathic potencies can be broadly classified into two major groups:
1. The low potencies which contain original drug molecules (probably up to 12c)
2. High potencies which do not contain drug molecules (probably above 12c)
(Here, the specified probability range is calculated for molecules of lowest molecular weight, using Avogadro Number. Obviously, molecules of higher molecular weight may disappear from the medium at much earlier stages of potentization. Probability range of each individual class of molecules can be calculated using their molecular weight, Avogadro Number and proportions of dilutions).
Low potencies contain original drug molecules acting as ‘Competitive Molecular Factors’(CMF) towards pathologic molecules.
High potencies contain molecular ‘imprints’ acting as ‘Counteractive Complementary Factors’(CCF) towards pathologic molecules.
A “drug” means, a sample of substance containing chemical molecules, that can interact with biological molecules, effecting deviations in biological processes. Normally, when a drug substance is introduced into an organism, the constituent drug molecules exhibit their action in any of the following ways:
1. Acting on various structural membranes, deranging their permeability.
2. Engaging in chemical reactions with various molecular substrates and metabolites inside the body.
3. Interacting with enzyme proteins, and other complex bio-molecules, thereby inactivating or incapacitating them for biochemical processes.
4. Interaction with various structural proteins.
5. Interacting with carrier proteins.
6. Interaction with ion channels.
7. Binding to Hormone receptors, and Neuro-transmitter receptors.
Drug molecules and their derivatives, due to their gross molecular properties, can chemically interact with biological molecules and metabolites. This phenomenon is utilized when drugs are used as allopathic medicines.
When crude drugs and low potencies are applied as ‘similimum’, the ‘drug’ molecules contained in them, if having configurational similarity to the active groups of pathological molecules, may compete with the pathological molecules in binding to the target bio-molecules, and in that process, relieve the bio-mole\cules from pathological inhibitions. In this case, drug molecules act as ‘competitive molecular factors’ (CMF) towards pathologic molecules. It should be understood that crude drugs and low potencies act in certain cases as therapeutic agents by this ‘competitive’ mechanism, when selected according to the principle of ‘similia similibus curentur’.
The problem with these ‘molecular forms of drugs being used as similimum is that, even though they may act curatively, they can cause off target molecular inhibitions in unexpected biological targets, causing new diseases in the long run. Only molecular imprints forms are safe from this angle.
In certain situations, where there is real scarcity of certain molecules necessary for metabolism, crude substances and low potencies or mother tinctures will have to be used by their supplementary or nutritional value. This belongs to Nutritional Therapy, and should not be confused with homeopathy. Various minerals, vitamins, co-factors, micro-nutrients and amino-acid supplements belong to this category.
A more logical and scientifically viable model is required, to explain the therapeutic effects of high potency homeopathic preparations. Potentized homeopathic medicine, when introduced into the organism by any route, is carried by the body fluids, and transported to different parts of body by internal transport system. When the nano-cavities of ‘molecular imprints’ contained these preparations come in the vicinity of active groups of pathological foreign molecules, having similarity to the original ‘guest’ molecules used for imprinting, these ‘molecular imprints’ selectively bind to the pathological molecules due to configurational affinity. By this process, pathological foreign molecules are prevented from binding to biological molecules, thereby relieving the biological molecules from pathological molecular blocks. This can be conceived as some sort of ‘molecular scavenging’ or ‘entrapping’ of pathological molecules, by ‘hydrosomes’ or molecular ‘imprints’ contained in the potentized medicines.
Drugs potentized above ‘Avogadro limit’ act by an entirely different molecular mechanism. ‘Hydrosomes’ or ‘molecular imprints’ formed during potentization are configurational complementaries of original drug molecules used as ‘guest’ for potentization. These ‘molecular imprints’ act as ‘counteractive complementary factors’ (CCF) and bind to the active groups of pathologic molecules having configurational similarity to the drug molecules used for potentization. Thus the pathologic molecules are prevented from interacting with the bio-molecules, thereby relieving the molecular bocks and pathological inhibitions. The danger of drug molecules acting upon on off-target sites, with unfavorable consequences should be expected while using crude drugs and low potencies. If we want to practice real homeopathy, we should deliberately abstain from using medicinal preparations containing drug molecules.
We should also be aware of the difference between crude drugs and low potencies or triturations. Even though both preparations contain same drug molecules, their therapeutic properties are found to be different. In crude form, drug molecules are packed tightly, with their chemical bonds remaining saturated by interacting with various other molecules or ions. Hence, they are not at all free to exhibit all their individual interactive potentials. Whereas in triturations and low potencies, the drug molecules are free or ionized, they can exhibit all their properties. Hence, pathologic and therapeutic capabilities of triturations and low potencies are much higher to crude forms of same drug, whereas drugs of toxic nature are more toxic in crude forms than dilutions, due to their high concentration of molecules. We already know that various drugs which appear comparatively inert in their crude forms become very potent medicinal agents in triturated forms. Differences between crude Siliciea and Silice 3x, crude Lyco and Lyco 3x etc. are examples for this phenomenon.
To get an answer to the question how ‘hormesis’ works or ‘small doses’ work, we have to understand the process of ‘dilution’ in terms of ‘size’ of drug molecules. Any drug substance of animal or vegetable origin contain diverse types of drug molecules. Some complex molecules will be very ‘big’ in size, and their number in a given quantity of solution will be comparatively very small as per avogadro theory. Smaller molecules will be present in larger quantities. When we start diluting serially, larger molecules will be ‘imprinted’ into the medium, and molecules get removed from the solution in very early stages of dilution process. Smaller molecules undergo imprinting and removal at later stages only. By reaching 12 c, even the smallest molecules get imprinted and removed. That is why I say potencies above 12c contain molecular imprints only.
Obviously, lower potencies below 12c will be a mixture of small molecules as well as molecular imprints of larger molecules. We can explain hormesis, hippocrates phenomenon and low potency therapeutics from this point of view.
Molecular forms of drugs (Crude and Low potencies) can act ‘homeopathically’, but the molecular mechanism of action is different from that of similimum in ‘molecular imprints’ forms (potencies above avogadro limit).
SIMILIMUM means a drug having molecules with functional moieties similar to those of pathogenic molecules. When similimum is used in molecular forms, they can ‘compete’ with pathogenic molecules in binding to biological targets. In biochemical interactions, such a competitive relationship leads to freeing of biological molecules from pathological inhibitions. It is liketwo identical keys trying to enter same key hole, which prevents both keys from entering the keyhole.
Molecular imprints of ‘similimum’ are ‘artificial key holes’ that have special affinity to the pathogenic molecules, which consists of ‘molecular key’, which are actually ‘fake keys’ trying to mimic natural ligands which are ‘original keys’, and biological targets are their ‘natural key holes’. Artificial key holes of molecular imprints bind to the pathogenic molecules due to configurational affinity, thereby relieving biological molecules from pathological inhibitions. This is the exact molecular mechanism of homeopathic cure produced by potentized drugs.
It is obvious that both molecular forms and molecular imprints forms of similimum can produce homeopathic cure, even though by fundamentally different molecular mechanisms. The draw back of using molecular forms of similimum is that being molecules, they can bind to unexpected biological targets, producing new inhibitions and pathologies, which we call side effects or unwanted effects. When using molecular imprints forms of similimum, they can bind only to pathogenic molecules having affinity, and cannot produce any new molecular inhibitions, as they consist of only water and ethyl alcohol molecules. That means, using similimum in crude forms and low potencies can have dangerous consequences exactly similar to allopathic drugs, where as using similimum in potentized forms above avogadro limit is completely safe.